Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets.
Beumers L, Vlachavas EI, Borgoni S, Schwarzmüller L, Penso-Dolfin L, Michels BE, Sofyali E, Burmester S, Heiss D, Wilhelm H, Yarden Y, Helm D, Will R, Goncalves A, Wiemann S.
Beumers L, et al. Among authors: penso dolfin l.
NPJ Breast Cancer. 2023 Dec 2;9(1):97. doi: 10.1038/s41523-023-00604-4.
NPJ Breast Cancer. 2023.
PMID: 38042915
Free PMC article.